The MASTL gene helps control cell division, so new cells copy and separate their chromosomes in an orderly way. This gene plays an important role in keeping that timing precise. If it does not work properly, cells can divide out of step, and some people may have an inherited low platelet count, sometimes along with other effects on growth or development.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Others mainly guide when certain processes take place, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
MASTLGene function
What if the gene works
The MASTL gene helps control cell division by keeping the timing of key steps in order. This supports normal growth, tissue repair, and accurate handling of chromosomes as cells split into two.
Risk
What if the gene does not work
Pathogenic variants in the MASTL gene cause inherited low platelet counts, sometimes with mild anemia from abnormal red blood cell development. Effects can range from mild bruising to more noticeable bleeding, depending on the variant.
Treatment
What does that mean for your treatment
No MASTL-specific treatment or management approach is currently established. The MASTL gene is being studied as a possible cancer drug target and biomarker because altered MASTL activity may influence tumor growth and treatment response.
Conditions associated with MASTL
Gene function
What if the gene works
Your cells rely on the MASTL gene during the part of the cell cycle when one cell divides into two. It helps keep the timing of division orderly, so key steps happen in the right sequence. Understanding MASTL gene function helps explain how cells copy and share their genetic material in a controlled way.
The MASTL gene helps cells move through mitosis, the stage when copied chromosomes are sorted into two new cells. It keeps important division signals active long enough for each step to happen in order.
Through its protein, the MASTL gene adds phosphate tags that help restrain PP2A-B55, a protein that removes these signals. This balance keeps many cell division proteins in the right state at the right time.
By maintaining these signals, the MASTL gene supports chromosome alignment and even separation as cells divide. In simple terms, it helps each new cell receive a full set of genetic instructions.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more markedly and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MASTL gene can change the protein’s shape, stability, or kinase activity (its ability to add small phosphate tags to other proteins). This is how variants in the MASTL gene affect its function at a cellular level: milder variants may leave some activity intact, while more severe variants can greatly reduce or stop signaling through ENSA and ARPP19, two proteins that help control the timing of cell division. In some cases, the protein is also broken down more easily, which further lowers its effect inside cells.
How variants are linked to conditions
Among the conditions linked to MASTL gene variants, the best established is inherited thrombocytopenia, where a low platelet count can lead to easy bruising, nosebleeds, or heavier periods. Pathogenic variants in the MASTL gene can cause inherited thrombocytopenia in some families. Symptoms vary widely, and some people have only mild bleeding problems despite clearly reduced platelets on blood tests.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the MASTL gene. Risk mainly depends on the exact gene change and the condition it is linked to in a family, so personal guidance from a doctor or genetic counselor can help put that risk in context.
Inheritance of MASTL variants
For families trying to understand how MASTL variants are inherited, the best-established pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the MASTL gene can pass it to a child, with a 50% chance in each pregnancy. Sons and daughters are affected equally because the MASTL gene is on a non-sex chromosome. In many families, the variant is seen across generations, with an affected parent passing it to a child.
What does my MASTL result mean for my family?
A disease-causing change in the MASTL gene is usually passed down in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In families with a MASTL-related platelet condition, symptoms can differ from one person to another, and some relatives may have only mild low platelets or easy bruising.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the MASTL gene, doctors use genetic testing for MASTL variants on a blood or saliva sample. A lab reads the gene’s DNA code and compares it with the usual sequence to look for changes. Results may show a known variant, no variant, or a change that needs further interpretation.
When should I consider getting a genetic test?
Consider MASTL testing if you or your child has lifelong low platelet counts, easy bruising, or unusual bleeding, especially when it runs in the family. It may also help explain low platelets with certain red blood cell changes or mild anemia.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it differently because their bodies break down, move, or respond to a drug in different ways. This is common and can influence how well a medicine works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medications. It focuses on links between genes and drugs to clarify why the same treatment can work differently from one person to another. For many medicines, genes influence both how the body handles a drug and how strong its effects are. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the MASTL gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication response, so questions about treatment choices, side effects, or drug safety are best discussed with your doctor. MASTL is being studied in cancer research because its activity may influence how some tumors respond to certain treatments, but this is not part of routine care.
History
Researchers first recognized the gene now called the MASTL gene through work on cell division in model organisms, where a related protein was known as Greatwall. Early studies in fruit flies during the 1990s and 2000s showed that changes in this pathway disrupted the normal timing of cell division, drawing wider interest to the human version of the gene. Building on this early work, scientists uncovered more about the gene as human cell studies linked MASTL to key checkpoints that help cells divide in an orderly way. As genetic testing expanded, rare inherited variants in the MASTL gene were identified in some families with platelet conditions, which broadened medical awareness of its clinical relevance. Over time, descriptions became more precise as cancer research also began examining how altered MASTL activity may influence tumor behavior.